Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · September 19, 2021

Triglyceride–Glucose Index vs HOMA-IR for Predicting the Prevalence and Incidence of T2D

Diabetes Research and Clinical Practice

 

Additional Info

Diabetes Research and Clinical Practice
The triglyceride–glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance
Diabetes Res. Clin. Pract. 2021 Sep 07;[EPub Ahead of Print], H Min Park, H Sun Lee, YJ Lee, JH Lee

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading